Sorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France.
IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France.
Mol Metab. 2020 Dec;42:101083. doi: 10.1016/j.molmet.2020.101083. Epub 2020 Sep 18.
Individuals born with intrauterine growth retardation (IUGR) are more prone to cardio-metabolic diseases as adults, and environmental changes during the perinatal period have been identified as potentially crucial factors. We have studied in a preclinical model early-onset molecular alterations present before the development of a clinical phenotype.
We used a preclinical mouse model of induced IUGR, in which we modulated the nutrition of the pups during the suckling period, to modify their susceptibility to cardio-metabolic diseases in adulthood.
Mice born with IUGR that were overfed (IUGR-O) during lactation rapidly developed obesity, hepatic steatosis and insulin resistance, by three months of age, whereas those subjected to nutrition restriction during lactation (IUGR-R) remained permanently thin and highly sensitive to insulin. Mice born with IUGR and fed normally during lactation (IUGR-N) presented an intermediate phenotype and developed insulin resistance by 12 months of age. Molecular alterations to the insulin signaling pathway with an early onset were observed in the livers of adult IUGR-N mice, nine months before the appearance of insulin resistance. The implication of epigenetic changes was revealed by ChIP sequencing, with both posttranslational H3K4me3 histone modifications and microRNAs involved.
These two changes lead to the coherent regulation of insulin signaling, with a decrease in Akt gene transcription associated with an increase in the translation of its inhibitor, Pten. Moreover, we found that the levels of the implicated miRNA19a-3p also decreased in the blood of young adult IUGR mice nine months before the appearance of insulin resistance, suggesting a possible role for this miRNA as an early circulating biomarker of metabolic fate of potential use for precision medicine.
宫内生长迟缓(IUGR)出生的个体成年后患心血管代谢疾病的风险更高,围产期的环境变化已被确定为潜在的关键因素。我们在临床前模型中研究了在临床表型出现之前存在的早期分子改变。
我们使用了一种诱导性 IUGR 的临床前小鼠模型,在该模型中,我们在哺乳期调节幼崽的营养,以改变它们成年后患心血管代谢疾病的易感性。
哺乳期过度喂养的 IUGR 小鼠(IUGR-O)在三个月大时迅速发展为肥胖、肝脂肪变性和胰岛素抵抗,而哺乳期接受营养限制的小鼠(IUGR-R)则保持永久性消瘦和对胰岛素高度敏感。哺乳期正常喂养的 IUGR 小鼠(IUGR-N)表现出中间表型,在 12 个月大时出现胰岛素抵抗。在 IUGR-N 成年小鼠的肝脏中观察到胰岛素信号通路的早期起始的分子改变,在胰岛素抵抗出现前九个月。ChIP 测序揭示了表观遗传变化的影响,涉及翻译后 H3K4me3 组蛋白修饰和 microRNAs。
这两种变化导致胰岛素信号的协调调节,Akt 基因转录减少与其抑制剂 Pten 的翻译增加相关。此外,我们发现,在胰岛素抵抗出现前九个月,年轻的 IUGR 小鼠的血液中也降低了所涉及的 miRNA19a-3p 的水平,这表明该 miRNA 作为代谢命运的早期循环生物标志物具有潜在的应用价值,用于精准医学。